RECURRENT CHILDHOOD EPENDYMOMA
Clinical trials for RECURRENT CHILDHOOD EPENDYMOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CHILDHOOD EPENDYMOMA trials appear
Sign up with your email to follow new studies for RECURRENT CHILDHOOD EPENDYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug shows promise for kids with aggressive brain cancers
Disease control OngoingThis study tests a drug called pembrolizumab in children whose brain tumors have come back or not responded to treatment. The drug helps the body's immune system fight cancer cells. The goal is to find the safest dose and see if it can shrink tumors in children with several types…
Matched conditions: RECURRENT CHILDHOOD EPENDYMOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:23 UTC
-
New hope for kids with rare cancers: targeted drug shows promise in early trial
Disease control OngoingThis study tested a drug called erdafitinib in children and young adults (ages 1 to 21) whose cancers had come back or were not responding to treatment. The drug targets cancers with specific changes in FGFR genes. The main goal was to see if the drug could shrink tumors. About 2…
Matched conditions: RECURRENT CHILDHOOD EPENDYMOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:54 UTC